Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
Posted inAlzheimer's Disease Cassava Sciences Inc City University of New York Clinical Trials Dementia Drugs (Pharmaceuticals) Falsification of Data Food and Drug Administration Regulation and Deregulation of Industry Securities and Commodities Violations Securities and Exchange Commission United States Wang, Hoau-Yan

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
Tesla Sales Increase, Suggesting Electric Car Demand Is Rebounding
Posted inAutomobiles Batteries Biden, Joseph R Jr China Company Reports Driverless and Semiautonomous Vehicles Electric and Hybrid Vehicles Europe Germany Global Warming Innovation Interest Rates Musk, Elon Prices (Fares, Fees and Rates) Stocks and Bonds Tesla Motors Inc Trump, Donald J United States

Tesla Sales Increase, Suggesting Electric Car Demand Is Rebounding

The automaker reported a gain of 6.4 percent for the latest quarter, its first such increase this year.
F.T.C. Clears Chevron’s Purchase of Hess With Board Condition
Posted inBoards of Directors Chevron Corporation Federal Trade Commission Guyana Hess Corporation Hess, John B. Mergers, Acquisitions and Divestitures Natural Gas Oil (Petroleum) and Gasoline Organization of the Petroleum Exporting Countries Regulation and Deregulation of Industry United States Wirth, Michael K

F.T.C. Clears Chevron’s Purchase of Hess With Board Condition

The Federal Trade Commission said the oil giant can acquire the smaller company as long as the chief executive of Hess does not join its board.